High-density lipoprotein – Page 2 – Communicable Diseases Research

Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study

낮은 고밀도 지단백 수치는 COVID-19 환자의 중증도와 상관관계가 있습니다: 관찰 연구

Research

Published on 2020-09-072022-08-13
Journal: Lipids in Health and Disease [Category] Biochemistry, COVID-19, SARS,

[키워드] 95% CI Admission adopted age age and gender blood lipid blood lipid level blood lipid levels C-reactive protein C-reactive protein (CRP China cholesterol Clinical data coronavirus disease Coronavirus disease 2019 correlated correlation COVID-19 COVID-19 adult patients COVID-19 patient COVID-19 patients Cox regression analysis diagnosed elevated enrolled event events Gender HDL-C healthy high-density High-density lipoprotein High-density lipoprotein cholesterol higher risk infected with COVID-19 interquartile range Kaplan-Meier LDL-C lipoprotein cholesterol Lipoproteins Low-density lipoprotein Low-Density Lipoprotein cholesterol male Mann-Whitney test median non-severe patients participant Patient Prognosis proportion RANK Result Retrospective analysis Severe case severe cases severe COVID-19 patient severe COVID-19 patients severity of COVID-19 significantly lower Total cholesterol Triglyceride underlying diseases were used
[DOI] 10.1186/s12944-020-01382-9 PMC 바로가기 [Article Type] Research

Exercise intervention alters HDL subclass distribution and function in obese women

운동 중재는 비만 여성의 HDL 하위 분류 분포와 기능을 변경합니다.

Research

Published on 2018-10-102022-09-06
Journal: Lipids in Health and Disease [Category] Communicable Disease,

[키워드] activating activity Adhesion Molecule aerobic African Alter Analysis Anti-inflammatory anti-inflammatory function Antioxidative assigned Blood body mass body mass index cardiovascular risk cell adhesion molecule cellular cholesterol Cholesterol efflux clinical condition controls decrease distribution endothelial exercise Exercise intervention expression HDL HDL structure HDL subclass high-density High-density lipoprotein Intervention Level modify obese obese patients obesity Platelet platelet activating factor Randomly reduce reduction in resistance exercise Result serum South subclass supplementary material Trial vascular cell adhesion venous venous blood were measured western blotting women
[DOI] 10.1186/s12944-018-0879-1 PMC 바로가기 [Article Type] Research

Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients

HIV 양성 환자에서 로수바스타틴 적정 단독요법과 비교한 에제티미브와 로수바스타틴 병용요법의 지질강하 효능 및 안전성

Research

Published on 2015-06-192022-09-06
Journal: Lipids in Health and Disease [Category] Communicable Disease,

[키워드] addition AIP ALT Antiretroviral therapy API apoA1 ApoB Apolipoprotein B appear AST baseline characteristics C-reactive protein change Characteristics cholesterol clinical symptom Clinical symptoms clinical trial Combination combination treatment develop dose dyslipidemia dyslipidemias Efficacy Efficacy and safety eligible examined Ezetimibe group groups guideline HDL-C High-density lipoprotein High-density lipoprotein cholesterol High-sensitivity C-reactive protein HIV HIV-infected patient HIV-infected patients hsCRP improvement increase in LDL-C Lipid lipid profile Low-density lipoprotein Low-Density Lipoprotein cholesterol Mild minimum monotherapy myalgias not differ Open-label parameter Patient patients with HIV percentage plasma Primary outcome Randomized Result Rosuvastatin Safe Significant statin targets therapy Total cholesterol Transport treatment groups Trial Triglyceride two patients
[DOI] 10.1186/s12944-015-0054-x PMC 바로가기 [Article Type] Research